Support Alert

Dexamethasone approved by the NHS for treatment of COVID-19 in hospitalised patients

The RECOVERY trial has shown that dexamethasone can reduce the mortality from COVID 19 in hospitalised patients who require oxygen or ventilation. Further details can be found on the National Institute for Health Research website

The significance of the results together with the safety profile of the medicine has led to advance approval by the NHS of Dexamethasone as a treatment for COVID-19. Further details and the press release can be found on the website

The Chief Medical Officers has issued a letter with supporting clinical information. This emphasises that treatment with Dexamethasone out of hospital is not appropriate and no benefits were shown in the trial for COVID-19 patients who did not need oxygen. Details of the letter can be found here